Amylx Pharmaceuticals Inc vs Datadog Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Datadog Inc trades at $245.99 (market cap $88.61B). The key difference: Datadog Inc is far larger — about 33.6× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Datadog Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | DDOG | |
|---|---|---|
Market Cap | $2.64B | $88.61B |
Sector | Health | Technology |
52-Week High | $24.19 | $288.15 |
52-Week Low | $7.82 | $102.62 |
Enterprise Value | $2.39B | $84.90B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →